Advertisement

Journal of Anesthesia

, Volume 29, Issue 4, pp 585–592 | Cite as

Efficacy of palonosetron and ramosetron on postoperative nausea and vomiting related to intravenous patient-controlled analgesia with opioids after gynecological laparoscopic surgery (double-blinded prospective randomized controlled trial)

  • Seong-Hyop KimEmail author
  • Chung-Sik Oh
  • Sun Joo Lee
Original Article

Abstract

Purpose

The study was designed to assess the efficacy of palonosetron and ramosetron in preventing postoperative nausea and vomiting (PONV) related to intravenous (IV) patient-controlled analgesia (PCA) with opioids after gynecological laparoscopic surgery.

Methods

Patients were randomly allocated to 4 groups—C, P, R0.3 and RPCA. At the end of surgery, group C received an infusion of 50 ml normal saline, group P received palonosetron 75 μg mixed in 50 ml normal saline, and groups R0.3 and RPCA received ramosetron 0.3 mg mixed in 50 ml normal saline. A PCA pump containing fentanyl was connected for all groups; however, ramosetron 0.6 mg was mixed with the PCA regimen for the RPCA group. PONV and postoperative pain were assessed.

Results

PONV incidence and scale, and Rhodes index in RPCA group between 24 and 72 h after discharge from the post-anesthetic care unit (PACU) showed significantly lower values, compared with the other groups. PONV incidence and scale, and Rhodes index in P group and R0.3 group were lower than the corresponding values in C group at all times, without statistical significance.

Conclusion

A single dose of palonosetron 75 μg or ramosetron 0.3 mg was unable to prevent PONV related to IV PCA with opioids in patients undergoing gynecological laparoscopic surgery. The combination of a single dose of ramosetron 0.3 mg, followed by ramosetron 0.6 mg mixed with PCA, significantly decreased PONV compared with a single dose of palonosetron 75 μg or ramosetron 0.3 mg.

Keywords

Postoperative nausea and vomiting Patient-controlled analgesia Opioids 

Notes

Acknowledgments

This research was supported by the Basic Science Research Programme through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (grant number: 2012R1A1A1001819). It was presented as an oral presentation in Anesthesiology™ 2014 annual meeting.

Conflict of interest

None.

References

  1. 1.
    Choi DH, Ko JS, Ahn HJ, Kim JA. A Korean predictive model for postoperative nausea and vomiting. J Korean Med Sci. 2005;20:811–5.PubMedCentralCrossRefPubMedGoogle Scholar
  2. 2.
    Gan TJ. Risk factors for postoperative nausea and vomiting. Anesth Analg. 2006;102:1884–98.CrossRefPubMedGoogle Scholar
  3. 3.
    Millo J, Siddons M, Innes R, Laurie PS. Randomised double-blind comparison of ondansetron and droperidol to prevent postoperative nausea and vomiting associated with patient-controlled analgesia. Anaesthesia. 2001;56:60–5.CrossRefPubMedGoogle Scholar
  4. 4.
    Dresner M, Dean S, Lumb A, Bellamy M. High-dose ondansetron regimen vs droperidol for morphine patient-controlled analgesia. Br J Anaesth. 1998;81:384–6.CrossRefPubMedGoogle Scholar
  5. 5.
    Cherian VT, Smith I. Prophylactic ondansetron does not improve patient satisfaction in women using PCA after Caesarean section. Br J Anaesth. 2001;87:502–4.CrossRefPubMedGoogle Scholar
  6. 6.
    Carlisle JB, Stevenson CA. Drugs for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev. 2006;3:CD004125.PubMedGoogle Scholar
  7. 7.
    Choi DK, Chin JH, Lee EH, Lim OB, Chung CH, Ro YJ, Choi IC. Prophylactic control of post-operative nausea and vomiting using ondansetron and ramosetron after cardiac surgery. Acta Anaesthesiol Scand. 2010;54:962–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Gómez-Hernández J, Orozco-Alatorre AL, Domínguez-Contreras M, Oceguera-Villanueva A, Gómez-Romo S, Alvarez Villaseñor AS, Fuentes-Orozco C, González-Ojeda A. Preoperative dexamethasone reduces postoperative pain, nausea and vomiting following mastectomy for breast cancer. BMC Cancer. 2010;10:692.PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Rhodes VA, McDaniel RW. The index of nausea, vomiting, and retching: a new format of the index of nausea and vomiting. Oncol Nurs Forum. 1999;26:889–94.PubMedGoogle Scholar
  10. 10.
    Candiotti KA, Kovac AL, Melson TI, Clerici G, Joo Gan T. Palonosetron 04-06 Study Group. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting. Anesth Analg. 2008;107:445–51.CrossRefPubMedGoogle Scholar
  11. 11.
    Kovac AL, Eberhart L, Kotarski J, Clerici G, Apfel C. Palonosetron 04-07 Study Group. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72 hour period. Anesth Analg. 2008;107:439–44.CrossRefPubMedGoogle Scholar
  12. 12.
    Kim SI, Kim SC, Baek YH, Ok SY, Kim SH. Comparison of ramosetron with ondansetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery. Br J Anaesth. 2009;103:549–53.CrossRefPubMedGoogle Scholar
  13. 13.
    De Leon A. Palonosetron (Aloxi): a second-generation 5-HT3 receptor antagonists for chemotherapy-induced nausea and vomiting. Proc (Bay Univ Med Cent). 2006;19:413–6.Google Scholar
  14. 14.
    Ye Moon, Joo J, Kim JE, Lee Y. Anti-emetic effect of ondansetron and palonosetron in thyroidectomy: a prospective, randomized, double blind study. Br J Anaesth. 2012;108:417–22.CrossRefGoogle Scholar
  15. 15.
    Bajwa SS, Bajwa SK, Kaur J, Sharma V, Singh A, Singh A, et al. Palonosetron: a novel approach to control postoperative nausea and vomiting in day care surgery. Saudi J Anaesth. 2011;5:19–24.PubMedCentralCrossRefPubMedGoogle Scholar
  16. 16.
    Park SK, Cho EJ, Kang SH, Lee YJ, Kim DA. A randomized, double-blind study to evaluate the efficacy of ramosetron and palonosetron for prevention of postoperative nausea and vomiting after gynecological laparoscopic surgery. Korean J Anesthesiol. 2013;64:133–7.PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    White PF, Scuderi PE. Prevention of postoperative nausea and vomiting (PONV): a dose-ranging study involving palonosetron, a potent 5-HT3 receptor antagonist. Anesthesiology. 2005;103:A703.Google Scholar
  18. 18.
    Jordan K, Kasper C, Schmoll HJ. Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment. Eur J Cancer. 2005;41(2):199–205.CrossRefPubMedGoogle Scholar
  19. 19.
    Habib AS, Gan TJ. Pharmacotherapy of postoperative nausea and vomiting. Expert Opin Pharmacother. 2003;4:457–73.CrossRefPubMedGoogle Scholar
  20. 20.
    Scuderi PE. PRO: anatomical classification of surgical procedures improves our understanding of the mechanisms of postoperative nausea and vomiting. Anesth Analg. 2010;110:410–1.CrossRefPubMedGoogle Scholar
  21. 21.
    Gralla RJ, Osoba D, Kris MG, Kirkbride P, Hesketh PJ, Chinnery LW, Clark-Snow R, Gill DP, Groshen S, Grunberg S, Koeller JM, Morrow GR, Perez EA, Silber JH, Pfister DG. Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J Clin Oncol. 1999;17:2971–94.PubMedGoogle Scholar
  22. 22.
    Kris MG, Hesketh PJ, Herrstedt J, Rittenberg C, Einhorn LH, Grunberg S, Koeller J, Olver I, Borjeson S, Ballatori E. Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy. Support Care Cancer. 2005;13:85–96.CrossRefPubMedGoogle Scholar
  23. 23.
    Herrstedt J, Rapoport B, Warr D, Roila F, Bria E, Rittenberg C, Hesketh PJ. Acute emesis: moderately emetogenic chemotherapy. Support Care Cancer. 2011;19:S15–23.CrossRefPubMedGoogle Scholar
  24. 24.
    Koeller JM, Aapro MS, Gralla RJ, Grunberg SM, Hesketh PJ, Kris MG, Clark-Snow RA. Antiemetic guidelines: creating a more practical treatment approach. Support Care Cancer. 2002;10:519–22.CrossRefPubMedGoogle Scholar
  25. 25.
    Chung F, Lane R, Spraggs C, McQuade B, Jacka M, Luttropp HH, Alahuta S, Rocherieux S, Roy M, Duvaldestin P, Curtis P. Ondansetron is more effective than metoclopramide for the treatment of opioid-induced emesis in post-surgical adult patients. Ondansetron OIE Post-Surgical Study Group. Eur J Anaesthesiol. 1999;16:669–77.CrossRefPubMedGoogle Scholar
  26. 26.
    Gan TJ, Diemunsch P, Habib AS, Kovac A, Kranke P, Meyer TA, Watcha M, Chung F, Angus S, Apfel CC, Bergese SD, Candiotti KA, Chan MT, Davis PJ, Hooper VD, Lagoo-Deenadayalan S, Myles P, Nezat G, Philip BK, Tramèr MR. Society for ambulatory anesthesia. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014;118:85–113.CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Society of Anesthesiologists 2015

Authors and Affiliations

  1. 1.Department of Anesthesiology and Pain MedicineKonkuk University Medical Center, Konkuk University School of MedicineSeoulKorea
  2. 2.Institute of Biomedical Science and TechnologyKonkuk University School of MedicineSeoulKorea
  3. 3.Department of Obstetrics and GynecologyKonkuk University Medical Center, Konkuk University School of MedicineSeoulKorea

Personalised recommendations